EVP, Chief Financial Officer
Tue, Feb 13, 2024
Feb 13
exercised or converted securities in TEVA
6,630 shares @ $0.00
Decreased holdings by -100.00%
Net across this filing: +6.70% (+6,630 shares)
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Health CarePharmaceuticals
1D0.00%
1W+0.96%
1M+19.47%
3M+6.36%
6M—
1Y—